Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 50 of 54 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company AimMax Therapeutics Inc. | Activity: Research and Development | Company Description AimMax Therapeutics researches and develops biopharmaceuticals for the treatment of infection, inflammation and pain through in-licensing or co-development with strategic partners. | Location Durham |
| |
Company Allergy Partners Extract Laboratory | Activity: Production and Manufacturing | Company Description Allergy Partners' Extract Laboratory produces extracts that are used to treat allergic disease, asthma and immunology. | Location Asheville |
| |
Company ALP Life Sciences Inc. | Activity: Research and Development | Company Description ALP Life Sciences has formulated and markets a High-3 fish oil supplement to increase omega-3 absorption and bioavailability for the treatment of fatty liver disease and inflammatory diseases. | Location Black Mountain |
| |
Company Altavera Analytics | Activity: Contract Research and Testing | Company Description Altavera Analytics provides custom solutions for bioinformatics, utilizing cloud-based workflows and statistical analysis of genomic data. Altavera specializes in biomedicine, including immunology and neurology, as well as agricultural applications, including plant molecular biology and CRISPR screens. | Location Durham |
| |
Company Amgen | Activity: Production and Manufacturing | Company Description Amgen will manufacture therapeutics for cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. The site is expected to be operational by 2025. | Location Apex |
| |
Company Antigenomycs Inc. | Activity: Research and Development | Company Description Antigenomycs is commercializing antigenome technology to measure complex antibody responses in health and disease. | Location Durham |
| |
Company Areteia Therapeutics Inc. | Activity: Research and Development | Company Description Areteia Therapeutics is developing the first oral drug for eosinophilic asthma. | Location Chapel Hill |
| |
Company AstraZeneca (Durham-Winchester) | Activity: Research and Development | Company Description AstraZeneca's Winchester Place site in Durham specializes in research and development across the biopharmaceuticals, vaccines and immune therapies, rare disease and oncology business units. | Location Durham |
| |
Company Attagene Inc. | Activity: Contract Research and Testing | Company Description Attagene has developed a pathway profiling technology to evaluate the impact of pharmaceuticals, environmental chemicals and natural products on over 100 transcription factors and 48 nuclear receptors. | Location Morrisville |
| |
Company Avicenna Biosciences Inc. | Activity: Research and Development | Company Description Avicenna Biosciences is a drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate optimization process for small molecule drug development. | Location Durham |
| |
Company Belhaven Biopharma Inc. | Activity: Research and Development | Company Description Belhaven Biopharma is developing dry powder nasal products for a variety of indications. | Location Raleigh |
| |
Company Bio Products Laboratory USA Inc. | Activity: Sales and Operations | Company Description Bio Products Laboratory (BPL) manufactures and distributes plasma-derived products, including intravenous immunoglobulin preparations, coagulation factors and albumin solution. U.S. Commercial Operations for BPL are based in Durham. | Location Durham |
| |
Company BioCryst Pharmaceuticals Inc. | Activity: Research and Development | Company Description BioCryst Pharmaceuticals designs and develops novel, small-molecule oral drugs that block key enzymes to treat rare diseases. The Durham location houses BioCryst's clinical, regulatory and executive teams. | Location Durham |
| |
Company Bryn Pharma LLC | Activity: Research and Development | Company Description Bryn Pharma is developing a nasal solution for the administration of emergency epinephrine for the treatment of anaphylaxis. | Location Raleigh |
| |
Company Caidya | Activity: Contract Research and Testing | Company Description Caidya provides full global CRO service to pharmaceutical and biotechnology companies, working across all major therapeutic areas including oncology, gastroenterology and women's health and rare disease. | Location Morrisville |
| |
Company Cellective BioTherapy Inc. | Activity: Research and Development | Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. | Location Chapel Hill |
| |
Company Cloud Pharmaceuticals Inc. | Activity: Contract Research and Testing | Company Description Cloud Pharmaceuticals designs and develops novel drug molecules using computational design for a wide range of therapeutic areas including cancer, inflammation, CNS disorders and rare diseases. | Location Research Triangle Park |
| |
Company Cognosci Inc. | Activity: Research and Development | Company Description Cognosci develops neurorestorative therapies for Alzheimer's disease, multiple sclerosis, traumatic brain injury, nerve crush and other disease and trauma indications. | Location Durham |
| |
Company CoImmune Inc. | Activity: Production and Manufacturing | Company Description CoImmune is an immuno-oncology company developing two cellular platform technologies. The CAR-CIK technology is a variation on CAR-T therapy being developed for liquid tumors and the RNA-loaded dendritic cell technology is being developed for solid tumors. | Location Durham |
| |
Company CrownBiome | Activity: Research and Development | Company Description CrownBiome is developing a dental microbiome diagnostic algorithm for the detection of local and systemic inflammation and disease. | Location Salisbury |
| |
Company CytexOrtho | Activity: Research and Development | Company Description CytexOrtho develops bio-artificial devices to treat osteoarthritis and other musculoskeletal diseases. | Location Durham |
| |
Company Diabetic Health Inc. | Activity: Research and Development | Company Description Diabetic Health develops coatings to improve the longevity and performance of continuous glucose monitoring sensors (CGM) and insulin infusion sets used in diabetes management. | Location Research Triangle Park |
| |
Company Emergo Therapeutics Inc. | Activity: Research and Development | Company Description Emergo Therapeutics develops drugs to reduce the production of inflammatory cytokines from mast cells and improve the functioning of the immune system in various potential indications, starting with infectious diseases. | Location Durham |
| |
Company Endacea Inc. | Activity: Research and Development | Company Description Endacea develops A1 adenosine receptor antagonists as drug candidates for cancer, COVID-19 acute lung injury, sepsis and acute renal failure. | Location Research Triangle Park |
| |
Company Genencine Therapeutics LLC | Activity: Research and Development | Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. | Location Durham |
| |
Company Gilead Sciences Inc. (Raleigh) | Activity: Sales and Operations | Company Description Gilead Sciences' Raleigh office houses the company's business services, human resource operations and information technology hub. | Location Raleigh |
| |
Company Global Vaccines Inc. | Activity: Research and Development | Company Description Global Vaccines is a not-for-profit company that develops vaccines against developing-country diseases such as HIV/AIDS, polio, dengue fever, malaria and viral diarrhea (rotavirus). | Location Chapel Hill |
| |
Company Grifols (Clayton) | Activity: Production and Manufacturing | Company Description Grifols' manufacturing campus in Clayton produces plasma-derived medicines and other biopharmaceutical solutions that treat patients with chronic, rare and, at times, life-threatening conditions. | Location Clayton |
| |
Company Grifols (RTP) | Activity: Sales and Operations | Company Description Grifols manufactures and markets plasma-derived medicines and other biopharmaceutical solutions to treat chronic, rare, and, at times, life-threatening conditions in the therapeutic areas of immunology, pulmonology, hematology, thrombolytics and neurology. | Location Research Triangle Park |
| |
Company GSK (Durham) | Activity: Research and Development | Company Description GSK develops and manufactures vaccines and medicines, with a focus on science related to the immune system, human genetics and advanced technologies. | Location Durham |
| |
Company Gusto Global LLC | Activity: Research and Development | Company Description Gusto Global is developing a discovery platform that integrates advanced computational and lab-based discovery tools to develop next-generation microbiome-based therapeutics & diagnostics. | Location Research Triangle Park |
| |
Company Hudson Therapeutics Inc. | Activity: Research and Development | Company Description Hudson Therapeutics, a subsidiary of Shaperon Inc., conducts global clinical trials and business development for anti-inflammatory and immunology drugs. | Location Research Triangle Park |
| |
Company Immorna Biotherapeutics Inc. | Activity: Research and Development | Company Description Immorna Biotherapeutics develops self-replicating and conventional mRNA-based therapeutics and vaccines. | Location Raleigh |
| |
Company Immunovant Inc. | Activity: Research and Development | Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. | Location Durham |
| |
Company IMMvention Therapeutix Inc. | Activity: Research and Development | Company Description IMMvention develops small molecule therapies that inhibit multiple inflammasome receptors to treat both rare and prevalent inflammatory diseases. | Location Research Triangle Park |
| |
Company Kaio Therapy LLC | Activity: Research and Development | Company Description KAIO Therapy develops an immunotherapy technology to treat solid tumors. | Location Raleigh |
| |
Company Mastezellen Bio Inc. | Activity: Research and Development | Company Description Mastezellen Bio is developing therapeutics for the treatment of diseases and disorders with mast cell involvement. | Location Research Triangle Park |
| |
Company Mizar Therapeutics | Activity: Research and Development | Company Description Mizar Therapeutics is a platform therapeutics company that provides drug discovery services using proprietary live-cell single-molecule imaging and machine-learning technology. | Location Chapel Hill |
| |
Company Mucommune LLC | Activity: Research and Development | Company Description Mucommune is developing a platform using monoclonal antibodies and mucus to reinforce the mucus barrier for female reproductive health. | Location Durham |
| |
Company NightHawk Biosciences | Activity: Research and Development | Company Description NightHawk Biosciences develops and commercializes immunotherapies to arm a patient's immune system against infectious disease, cancer and inflammation. | Location Morrisville |
| |
Company North Carolina Clinical Research | Activity: Contract Research and Testing | Company Description North Carolina Clinical Research conducts phase 1 through 4 trials at its outpatient clinical research facility. Study indications include allergy (seasonal and perennial), asthma, COPD, vaccine, migraine, bioequivalent studies and celiac disease. | Location Raleigh |
| |
Company Pfizer Inc. (Sanford) | Activity: Production and Manufacturing | Company Description Pfizer's Sanford facility manufactures clinical trial and commercial materials for conjugate vaccines and gene therapies. | Location Sanford |
| |
Company Priovant Therapeutics | Activity: Research and Development | Company Description Priovant is developing and commercializing targeted therapeutics for patients with severe autoimmune disease. | Location Durham |
| |
Company Qura Therapeutics LLC | Activity: Research and Development | Company Description Qura Therapeutics is discovering therapeutics for curing HIV/AIDS. Qura is a joint venture between ViV Healthcare and UNC-CH and provides financial, material and development support for therapies that emerge from research at the UNC HIV Cure Center. | Location Chapel Hill |
| |
Company RedHill Biopharma Inc. | Activity: Sales and Operations | Company Description RedHill Biopharma develops and commercializes orally-administered, small-molecule drugs for the treatment of gastrointestinal and inflammatory diseases, including cancer. Its Raleigh site is the company's U.S. commercial headquarters. | Location Raleigh |
| |
Company Renovion Inc. | Activity: Research and Development | Company Description Renovion is a clinical stage company developing therapies for chronic inflammatory lung diseases, including bronchiectasis, BOS in lung transplant and chronic bronchitis. | Location Chapel Hill |
| |
Company Sobi (Durham) | Activity: Research and Development | Company Description Sobi develops treatments for orphan diseases with a focus on inflammation and genetic diseases. | Location Durham |
| |
Company Stallergenes Greer | Activity: Production and Manufacturing | Company Description Stallergenes Greer develops and distributes animal and human allergy immunotherapy products and services. | Location Lenoir |
| |
Company Sumitomo Pharma America Inc. (Cary) | Activity: Research and Development | Company Description Sumitomo Pharma America develops regenerative therapeutics for rare diseases such as congenital athymia. | Location Cary |
| |
Company TG Therapeutics Inc. | Activity: Research and Development | Company Description TG Therapeutics is a commercial stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. | Location Morrisville |